Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells. 2014

Bianca Werner, and Sven Dittmann, and Carsten Funke, and Klaus Überla, and Cornelia Piper, and Karsten Niehaus, and Dieter Horstkotte, and Martin Farr
Department of Cardiology, Heart and Diabetes Center NRW, Ruhr University of Bochum, Georgstr. 11, 32545, Bad Oeynhausen, NRW, Germany, bwerner@hdz-nrw.de.

OBJECTIVE The coxsackie and adenovirus receptor (CAR) mediates the entry of coxsackievirus B (CVB) and adenovirus into host cells and is, therefore, a key determinant for the molecular pathogenesis of viral diseases such as myocarditis. The aim was to investigate the influence of HMG-CoA reductase inhibitor lovastatin on CAR expression in endothelial cells. METHODS Human umbilical vein endothelial cells (HUVECs) were exposed to different concentrations of lovastatin (0.05-5 μmol/l) for up to 48 h. Alterations in CAR expression were examined by quantitative real-time PCR (qRT-PCR) and flow cytometry. In addition, after treatment with 1 μmol/l lovastatin for 48 h, HUVECs were infected for 8 h with CVB3 and virus replication was detected by qRT-PCR using viral-specific TaqMan probes. RESULTS We found that lovastatin decreases CAR mRNA expression by up to 80% (p < 0.01) and CAR protein expression by up to 19% (p < 0.01), in a concentration-dependent manner. Moreover, virus replication of CVB3 was significantly inhibited after lovastatin treatment (p < 0.05). The signaling mechanism of CAR down-regulation by lovastatin depends on the Rac1/Cdc42 pathway. CONCLUSIONS This study shows for the first time that lovastatin reduces the expression of CAR and subsequently the replication of CVB3 in HUVECs.

UI MeSH Term Description Entries
D008148 Lovastatin A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver. Lovastatin, 1 alpha-Isomer,Mevinolin,6-Methylcompactin,Lovastatin, (1 alpha(S*))-Isomer,MK-803,Mevacor,Monacolin K,1 alpha-Isomer Lovastatin,6 Methylcompactin,Lovastatin, 1 alpha Isomer,MK 803,MK803,alpha-Isomer Lovastatin, 1
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003384 Coxsackievirus Infections A heterogeneous group of infections produced by coxsackieviruses, including HERPANGINA, aseptic meningitis (MENINGITIS, ASEPTIC), a common-cold-like syndrome, a non-paralytic poliomyelitis-like syndrome, epidemic pleurodynia (PLEURODYNIA, EPIDEMIC) and a serious MYOCARDITIS. Coxsackie Virus Infections,Infections, Coxsackie Virus,Infections, Coxsackievirus,Coxsackie Virus Infection,Coxsackievirus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D061307 Human Umbilical Vein Endothelial Cells Endothelial cells that line venous vessels of the UMBILICAL CORD. Human Umbilical Vein Endothelial Cell,Endothelial Cells, Human Umbilical Vein,HUVEC Cells,Cell, HUVEC,Cells, HUVEC,HUVEC Cell
D019161 Hydroxymethylglutaryl-CoA Reductase Inhibitors Compounds that inhibit HYDROXYMETHYLGLUTARYL COA REDUCTASES. They have been shown to directly lower CHOLESTEROL synthesis. HMG-CoA Reductase Inhibitor,HMG-CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Reductase Inhibitor,Statin,Statins, HMG-CoA,Inhibitors, HMG-CoA Reductase,Inhibitors, Hydroxymethylglutaryl-CoA,Inhibitors, Hydroxymethylglutaryl-Coenzyme A,Statins,HMG CoA Reductase Inhibitor,HMG CoA Reductase Inhibitors,HMG-CoA Statins,Hydroxymethylglutaryl CoA Reductase Inhibitor,Hydroxymethylglutaryl CoA Reductase Inhibitors,Hydroxymethylglutaryl-CoA Inhibitors,Hydroxymethylglutaryl-Coenzyme A Inhibitors,Inhibitors, HMG CoA Reductase,Inhibitors, Hydroxymethylglutaryl CoA,Inhibitors, Hydroxymethylglutaryl Coenzyme A,Inhibitors, Hydroxymethylglutaryl-CoA Reductase,Reductase Inhibitor, Hydroxymethylglutaryl-CoA,Reductase Inhibitors, HMG-CoA,Reductase Inhibitors, Hydroxymethylglutaryl-CoA,Statins, HMG CoA
D020764 cdc42 GTP-Binding Protein A member of the Rho family of MONOMERIC GTP-BINDING PROTEINS. It is associated with a diverse array of cellular functions including cytoskeletal changes, filopodia formation and transport through the GOLGI APPARATUS. This enzyme was formerly listed as EC 3.6.1.47. G25K GTP-Binding Protein, Placental Isoform,G25K Protein,cdc42 Protein,p21 cdc42,Cell Division Control Protein 42 Homolog,Cell Division Cycle 42 Protein,G25K GTP-Binding Protein,G25K GTP Binding Protein,G25K GTP Binding Protein, Placental Isoform,GTP-Binding Protein, G25K,GTP-Binding Protein, cdc42,cdc42 GTP Binding Protein,cdc42, p21
D020830 rac1 GTP-Binding Protein A rac GTP-binding protein involved in regulating actin filaments at the plasma membrane. It controls the development of filopodia and lamellipodia in cells and thereby influences cellular motility and adhesion. It is also involved in activation of NADPH OXIDASES. This enzyme was formerly listed as EC 3.6.1.47. TC-25 GTP-Binding Protein,rac1 Protein,ras-Related C3 Botulinum Toxin Substrate 1,GTP-Binding Protein, TC-25,GTP-Binding Protein, rac1,TC 25 GTP Binding Protein,rac1 GTP Binding Protein,ras Related C3 Botulinum Toxin Substrate 1

Related Publications

Bianca Werner, and Sven Dittmann, and Carsten Funke, and Klaus Überla, and Cornelia Piper, and Karsten Niehaus, and Dieter Horstkotte, and Martin Farr
November 2013, Journal of virology,
Bianca Werner, and Sven Dittmann, and Carsten Funke, and Klaus Überla, and Cornelia Piper, and Karsten Niehaus, and Dieter Horstkotte, and Martin Farr
August 2014, Medical microbiology and immunology,
Bianca Werner, and Sven Dittmann, and Carsten Funke, and Klaus Überla, and Cornelia Piper, and Karsten Niehaus, and Dieter Horstkotte, and Martin Farr
January 2004, Journal of cardiovascular pharmacology,
Bianca Werner, and Sven Dittmann, and Carsten Funke, and Klaus Überla, and Cornelia Piper, and Karsten Niehaus, and Dieter Horstkotte, and Martin Farr
January 1988, The Journal of general virology,
Bianca Werner, and Sven Dittmann, and Carsten Funke, and Klaus Überla, and Cornelia Piper, and Karsten Niehaus, and Dieter Horstkotte, and Martin Farr
October 2006, The Pediatric infectious disease journal,
Bianca Werner, and Sven Dittmann, and Carsten Funke, and Klaus Überla, and Cornelia Piper, and Karsten Niehaus, and Dieter Horstkotte, and Martin Farr
February 2012, Apoptosis : an international journal on programmed cell death,
Bianca Werner, and Sven Dittmann, and Carsten Funke, and Klaus Überla, and Cornelia Piper, and Karsten Niehaus, and Dieter Horstkotte, and Martin Farr
August 2000, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
Bianca Werner, and Sven Dittmann, and Carsten Funke, and Klaus Überla, and Cornelia Piper, and Karsten Niehaus, and Dieter Horstkotte, and Martin Farr
August 1994, Blood,
Bianca Werner, and Sven Dittmann, and Carsten Funke, and Klaus Überla, and Cornelia Piper, and Karsten Niehaus, and Dieter Horstkotte, and Martin Farr
August 2002, Wei sheng yan jiu = Journal of hygiene research,
Bianca Werner, and Sven Dittmann, and Carsten Funke, and Klaus Überla, and Cornelia Piper, and Karsten Niehaus, and Dieter Horstkotte, and Martin Farr
December 1996, Journal of virology,
Copied contents to your clipboard!